FindTrial
Sign In

Effect of low dose Atropine Eye drops in children with Short-Sightedness.

Effect of 0.01% Atropine in children with Myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017010
Enrollment
104
Registered
2019-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: 0.01% ATROPINE EYE DROPS: DOSE 0.01% FREQUENCY ONCE IN THE NIGHT DAILY ROUTE OF ADMINISTRATION TOPICAL EYE DROPS DURATION OF THERAPY ONE AND HALF YEARS Control Intervention1: Not Appli

Sponsors

RASHMI K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children both male and female aged 6-18 years with compound myopia of atleast -2.00D or more and astigmatism -1.50 D or less attending Ophthalmology OPD in Kasturba Medical College, Manipal

Exclusion criteria

Exclusion criteria: 1.Myopia due to glaucoma 2.Any ocular trauma 3.Any ocular surgery

Design outcomes

Primary

MeasureTime frame
Degree of myopia progression defined as change in spherical equivalent over 2 years study period as measured by cycloplegic refraction. Change in axial length as measured by IOL master. Timepoint: Degree of myopia progression defined as change in spherical equivalent over 2 years study period as measured by cycloplegic refraction. Change in axial length as measured by IOL master.—

Secondary

MeasureTime frame
Side effects of long term use of 0.01% Atropine eye dropsTimepoint: Assessed every 6 months for the period of 2 years—

Countries

India

Contacts

Public ContactRASHMI K

Kasturba Medical College, Manipal

pai.vijaya@manipal.edu9845426427

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026